Lantheus Holdings (NQ: LNTH )
106.47
+1.66
(+1.58%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Lantheus Holdings
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210527005291/en/840088/4/Lantheus%C2%AE_Holdings_370px.jpg)
![](https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2012/laboratory-2815641_1920_8_3.jpg)
Via Talk Markets
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/christina-victoria-craft-whsnkiwwpec-unsplash.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-2815641_1920_8_3.jpg)
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20210521005043/en/840088/4/Lantheus%C2%AE_Holdings_370px.jpg)
![](https://mms.businesswire.com/media/20210520005317/en/840088/4/Lantheus%C2%AE_Holdings_370px.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_332.jpg)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_63.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210504005364/en/840088/4/Lantheus%C2%AE_Holdings_370px.jpg)
![](https://mms.businesswire.com/media/20210503005135/en/840088/4/Lantheus%C2%AE_Holdings_370px.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pills-943764_1920_14.jpg)
![](https://mms.businesswire.com/media/20210430005074/en/840088/4/Lantheus%C2%AE_Holdings_370px.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medic-563423_1920_398_50.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/nerve-cell-2213009_1920_25.jpg)
Via Benzinga
![](https://mms.businesswire.com/media/20210420005150/en/840088/4/Lantheus%C2%AE_Holdings_370px.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_331.jpg)
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20210407005496/en/840088/4/Lantheus%C2%AE_Holdings_370px.jpg)
Lantheus Expands R&D Leadership Team with Key New Hires
April 07, 2021
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_62.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.